Birchview Capital, LP Prothena Corp Public LTD CO Transaction History

Birchview Capital, LP

$117 Million
Q4 2024

A detailed history of Birchview Capital, LP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Birchview Capital, LP holds 304,574 shares of PRTA stock, worth $2.8 Million. This represents 3.6% of its overall portfolio holdings.

Number of Shares

304,574

Previous 209,574 45.33%

Holding current value

$2.8 Million

Previous $3.51 Million 20.31%

% of portfolio

3.6%

Previous 3.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.95 - $18.35 $1.14 Million - $1.74 Million	95,000 Added 45.33%	304,574 $4.22 Million
Q3 2024 Nov 14, 2024	BUY	$16.73 - $24.79 $100,380 - $148,740	6,000 Added 2.95%	209,574 $3.51 Million
Q2 2024 Aug 13, 2024	BUY	$19.54 - $26.15 $664,360 - $889,100	34,000 Added 20.05%	203,574 $4.2 Million
Q3 2023 Nov 14, 2023	BUY	$47.3 - $70.6 $636,799 - $950,487	13,463 Added 8.62%	169,574 $8.18 Million
Q2 2023 Aug 08, 2023	BUY	$48.26 - $78.59 $1.34 Million - $2.18 Million	27,716 Added 21.59%	156,111 $10.7 Million
Q1 2023 May 12, 2023	BUY	$46.97 - $58.27 $56,364 - $69,924	1,200 Added 0.94%	128,395 $6.22 Million
Q4 2022 Feb 03, 2023	BUY	$52.05 - $65.0 $429,412 - $536,250	8,250 Added 6.94%	127,195 $7.66 Million
Q3 2022 Nov 07, 2022	BUY	$25.16 - $60.63 $412,548 - $994,150	16,397 Added 15.99%	118,945 $7.21 Million
Q2 2022 Aug 12, 2022	BUY	$22.73 - $39.98 $1.38 Million - $2.42 Million	60,570 Added 144.29%	102,548 $2.78 Million
Q1 2022 May 13, 2022	BUY	$30.27 - $49.22 $52,397 - $85,199	1,731 Added 4.3%	41,978 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$48.2 - $78.89 $482,000 - $788,900	10,000 Added 33.06%	40,247 $2.87 Million
Q2 2021 Aug 10, 2021	BUY	$21.63 - $57.65 $654,242 - $1.74 Million	30,247 New	30,247 $1.56 Million
Q4 2017 Feb 02, 2018	SELL	$35.44 - $63.76 $128,718 - $231,576	-3,632 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$53.83 - $67.75 $195,510 - $246,068	3,632	3,632 $235,000

Others Institutions Holding PRTA

# of Institutions

197

Shares Held

39.4M

Call Options Held

601K

Put Options Held

259K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $432M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Account

Birchview Capital, LP Prothena Corp Public LTD CO Transaction History